首页> 美国卫生研究院文献>Journal of Current Glaucoma Practice >The Surgical Treatment of Neovascular Glaucoma with Ex-PRESS P-50 Miniature Glaucoma Shunt
【2h】

The Surgical Treatment of Neovascular Glaucoma with Ex-PRESS P-50 Miniature Glaucoma Shunt

机译:用EX-PRESS P-50微型青光眼分流器对新生血管性青光眼的手术治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Surgical treatment for neovascular glaucoma has evolved from cyclodestructive procedures to full-thickness filtration surgery, to trabeculectomy with antifibrosis drugs and glaucoma drainage implant surgery. The choice of a surgical approach may be influenced by several factors, including the stage of the disease. Many surgeons favor drainage implants when the disease is more advanced or when severe inflammation is present, which would be associated with a poorer prognosis if trabeculectomy were chosen. New devices are being developed to allow surgeons increased control with more predictable postoperative results. One such device, the Ex-PRESS™ mini glaucoma shunt, has undergone changes in design and method of insertion making it more appealing for use in patients requiring IOP-lowering surgery. This report highlights the use of Ex-PRESS mini glaucoma shunt in neovascular glaucoma, surgical technique and summarize pertinent literature on the role of this device in glaucoma surgery.
机译:新生血管性青光眼的手术治疗已从环毁性手术发展到全层滤过手术,再到抗纤维化药物的小梁切除术和青光眼引流植入术。手术方法的选择可能受几个因素的影响,包括疾病的阶段。当疾病更严重或出现严重炎症时,许多外科医生倾向于使用引流植入物,如果选择小梁切除术,则预后较差。正在开发新的设备,以使外科医生可以更好地控制术后效果。一种这样的设备,即Ex-PRESS™微型青光眼分流器,在设计和插入方法方面发生了变化,使其更适合需要降低IOP的患者。该报告重点介绍了Ex-PRESS小型青光眼分流器在新生血管性青光眼中的应用,手术技术,并总结了有关该设备在青光眼手术中的作用的相关文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号